FINHUB Insights

PFE · Q1 FY26 · Mar 29, 2026

Pfizer Q1 FY26: where the revenue came from and where it went

Pfizer Q1 FY26: revenue $14.5B (+5% year over year). Net profit $2.7B. Largest cohort US $8.7B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 29, 2026
Reported
May 5, 2026 10-Q
Sankey diagram of Pfizer's income statement for Q1 FY26: revenue of $14.5 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$14.5B +5% year over year
Gross profit$10.9B 75% margin
Operating profit$-3.2B -22% margin
Net profit$2.7B 19% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 29, 2026).
ItemValueShare of revenueYear over year
Revenue 14.5 100% +5%
US 8.7 60% +4%
International Developed Markets 3.4 23% +8%
International Emerging Markets 2.3 16% +6%
Cost of revenue−3.524%
Gross profit10.975% margin−4pp
SG&A−320%−2pp
Other−11.177%+0pp
Operating profit-3.2-22% margin+0pp
Tax−0.4
Net profit2.719%−3pp
Filing on EDGAR More quarters of PFE

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters